In a patient with pleural effusion, first-line investigations for tuberculosis, if negative, are not conclusive.
A rapidly increasing pleural effusion In a patient with pleural effusion, first-line investigations for tuberculosis, if negative, are not conclusive.
CASE HISTORY
A Rwandan man aged 32 sought advice after two weeks of fever and malaise. He had returned to the UK three months previously from a visit to Uganda during which time he had not taken any malaria prophylaxis. On questioning, he said he had a dull ache in the left upper quadrant of his abdomen and lower back pain. His temperature was 38 8C. There were no focal signs in the chest but a chest radiograph revealed a small left pleural effusion. An ultrasound of his abdomen was unremarkable. Haemoglobin was 13.8 g/dL, white cell count 6.7610 9 /L, erythrocyte sedimentation rate 63 mm/h. Two blood films for malaria parasites were reported negative. Broad spectrum antibiotics were started. The left pleural effusion was aspirated under ultrasound guidance but no organisms, including acid-fast bacilli, were identified or subsequently cultured. Polymerase chain reaction (PCR) amplification for Mycobacterium tuberculosis DNA on the pleural aspirate was also negative. A Heaf test was read after seven days as grade I and a HIV test was negative. Despite ten days of antibiotics the patient continued to have a swinging pyrexia. A chest radiograph revealed that the left pleural effusion now occupied the entire hemithorax. A pleural biopsy was taken and 1.6 L of straw-coloured fluid was obtained via a chest drain. The fluid contained glucose 1.3 mmol/L, lactate dehydrogenase 2163 IU/L, protein 49 g/L; no malignant cells were identified. A definitive diagnosis was obtained from the pleural biopsy ( Figure 1 ). Several acid-fast bacilli were identified, and culture grew a fully sensitive M. tuberculosis.
The patient was then started on isoniazid, rifampicin, pyrazinamide and ethambutol without incident.
COMMENT Tuberculosis (TB) remains a global threat to human health, 1 and this diagnosis was considered throughout the patient's admission. However, several investigations for M. tuberculosis were negative. This is not unusual in pleural tuberculosis. Acid-fast bacilli were not identified in the pleural aspirate; but, unlike tuberculous empyemas, TB pleural effusions are probably generated by a delayed hypersensitivity reaction to mycobacterial antigens secreted into the pleural space rather than to the bacillus itself. 2 The relative non-reactivity to the Heaf test is also not unusual, with negative tests reported in up to 31% of patients. 3 Coinfection with HIV may also attenuate this test, but our patient was HIV-negative at the time of testing. PCR amplification assays for M. tuberculosis can provide a rapid diagnosis and estimation of drug sensitivities. 4 However, reduced sensitivity in pleural disease is thought to be due to the presence of natural inhibitors of the PCR amplification process. 4 Pleural biopsy with both histological and microbiological examination has been reported to have sensitivities of greater than 90% for this condition. 5 In patients with pleural disease, the presence of negative first-line investigations for tuberculosis should not exclude this diagnosis. A pleural biopsy should be considered. In an older person by far the most likely cause of shortlasting hemiplegia is a transient ischaemic attack, but other possibilities must be excluded.
A man of 79 was brought to hospital having been found collapsed on the floor. He was aphasic and unable to give a history. On examination he had a right hemiparesis with hyperactive reflexes and an extensor plantar response on that side. There was expressive dysphasia but comprehension was spared. Pupils were reactive to light and accommodation and there were no cranial nerve deficits. Carotid pulsations were normal with no bruit. A left hemisphere CVA was diagnosed provisionally, aspirin 300 mg was prescribed, and he was admitted to the ward pending a cerebral CT scan and the results of his blood tests. One hour later the nurses contacted the admitting physician to say that the patient's symptoms had fully resolved. Soon after that, the nurses contacted the physician to inform him that the hemiparesis had returned, but this time affecting the left side and sparing the right. The admitting team saw him again and confirmed that he now had a left-sided hemiparesis. At this stage, the blood results became available and revealed a blood glucose of 1.8 mmol/L. 100 mL 50% intravenous dextrose was given and the symptoms again resolved. In retrospect, the original resolution of symptoms had occurred after lunch on the ward. The patient, now able to give a history, confirmed that he had longstanding diabetes treated with glibenclamide 2.5 mg daily. He had taken two tablets that morning by mistake. A 10% glucose drip was continued overnight and he was discharged 24 hours later with normal glucose and no neurological deficits. The district nurse arranged for him to have his medications dosetted to avoid further drug errors.
Neither the casualty card nor the admission clerking indicated that an on-site blood glucose test had been done. A stroke proforma that requires documentation of such a test result has now been adopted.
COMMENT Neurogenic responses to hypoglycaemia, mediated by the release of adrenalin and noradrenalin, include palpitations, tremor, anxiety, hunger, paraesthesia and sweating. Neuroglycopenic symptoms, caused by neuronal dysfunction, include behavioural changes, confusion, fatigue, fits and coma. Focal neurological signs such as hemiparesis are a rare presenting feature easily mistaken for stroke.
In normal circumstances, hypoglycaemia is reversed by counter-regulatory responses, the most important of which is glucagon release by pancreatic alpha cells. Catecholamine release has a similar effect.
Elderly patients with diabetes mellitus seem especially prone to long-lasting hypoglycaemia, perhaps because their pancreatic alpha-cell function is subnormal 1 or because autonomic neuropathy results in a diminished catecholamine response. 2 Also, the response to hypoglycaemic medications is more pronounced and prolonged (glibenclamide, which has a half-life of 10-16 hours, has caused hypoglycaemia for up to 60 hours in elderly patients 3 ). Finally, elderly patients are at special risk of 'hypoglycaemia unawareness', missing the neurogenic signs so that the first manifestation of hypoglycaemia is neuroglycopenia, at which point they may be unable to take action. 4 The mechanism for hypoglycaemic brain injury is thought to be disturbance of cerebral energy metabolism. However, for localized effects such as hemiparesis, cerebral vascular spasm due to disturbed autoregulation seems a likely contributor. 5 With the new evidence favouring tight glycaemic control in type 2 diabetes mellitus, 6 hypoglycaemic episodes of all kinds will become more common.
